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Introduction {#sec001}
============

Cancer is the third cause of death and a major health issue in Iran \[[@pone.0155669.ref001]\]. Despite advanced medical knowledge the main etiology of cancer is not fully known. Assessing the incidence of cancer in various geographic distributions has had an effective role in developing new hypothesis that may not only address the potential etiology of cancer, but also helps to develop novel interventions to prevent cancer or screen the population at risk. The incidence rate within specific region changes through passing of time. While the true increment of cancer in an area could be explained by ever increasing exposure to carcinogens, however, the initial screening programs can show false increases because of early detection of cancer \[[@pone.0155669.ref002]\]. On the other hand, lifestyle modifications including healthy diet, sanitation (public health) and a well-established screening modalities, can truly reduce cancer incidence rate \[[@pone.0155669.ref003]\]. The cancer registries provide invaluable information for evaluating cancer occurrence in the context of descriptive epidemiology. The cancer registry in Fars province, southern Iran dates back to 1976 when it was established but its activities were limited to histopathologically confirmed cases without reference to a defined population \[[@pone.0155669.ref004]\]. The mentioned registry was interrupted because of the revolution and war in the early 1980s. In 1984, the parliament passed a bill mandating the report of all tissues "diagnosed or suspected as cancer" to the Ministry of Health \[[@pone.0155669.ref005]\]. In 1989, cancer registry in Fars province, southern Iran was resumed and collected the data from all potential resources including pathologic laboratories, radiology clinics, private and teaching hospitals. Monitoring cancer epidemiology changes over time which does not only determines cancer patterns, but also guide planning and evaluation of cancer control programs which helps to set priorities for allocating resources, advance clinical, epidemiologic, and health services research. Although there has been studies on this subject in the Fars province, to the best of our knowledge no study has been published on changing epidemiology of cancers in this region of Iran since the re-establishment of Fars cancer registry program.

Methods and Materials {#sec002}
=====================

Geography {#sec003}
---------

Fars province, with 122,400 km^2^ area (8% of the total land area of Iran, which is about 1,648,195 km^2^), is located in southern Iran \[[@pone.0155669.ref006]\]. It is about 5,000 feet above the sea level in a mountainous region of Zagros. Fars province has hot and dry summers, generally mild winters, and a great deal of sunshine throughout the year.

Fars population {#sec004}
---------------

According to the census 1999 and 2009 the total population of Fars province has increased from 3,817,033 (56.5% urban vs. 43.5% rural) to 4,336,878 (61.2% urban vs. 38.8% rural). The mean age (years) of men and women in Fars province has increased from 23.7 and 23.54 in year 1999 to 28.03 and 27.99 in 2009; that indicates aging of the population. [Fig 1](#pone.0155669.g001){ref-type="fig"} shows the population pyramids of Fars province in 1999 and 2009 \[[@pone.0155669.ref007], [@pone.0155669.ref008]\].

![Population pyramid of Fars province, 1999 and 2009.\
This figure provides population distributions in Fars province including both sexes from 1999 to 2009.](pone.0155669.g001){#pone.0155669.g001}

Medical care {#sec005}
------------

Comparing the census of 1999 with 2009 the total number of hospital beds had increased from 5,411 to 6,991 in the entire province \[[@pone.0155669.ref007], [@pone.0155669.ref008]\]. The physician to patient ratio rose from 1:4887 to 1:2681 in the past decade \[[@pone.0155669.ref007], [@pone.0155669.ref008]\].

Data collection and analysis {#sec006}
----------------------------

In this retrospective study we compared changes in the top ten cancer in our region during three periods; 1985--1989, 1998--2002, and 2007--2010. The raw data of 1985--1989 study was driven from data set that was gathered by Saalabian \[[@pone.0155669.ref009]\], and we calculated the age-standardized rates per 100,000 person-years (ASRs) for this time period. We published the data on cancer incidence in our region for 1998--2002 \[[@pone.0155669.ref010]\]. Recently, we conducted a study on cancer incidence in Fars province using data related to 2007 to 2010, ([S1 Table](#pone.0155669.s001){ref-type="supplementary-material"}). For calculating the cancer ASRs for 2007--2010, we used the data that was gathered from all hospitals, outpatient clinics, pathology laboratories, radiology clinics, and the central death registry office in Fars province cities. We excluded data for those who were nonresident patients who had seeked medical care in Fars province. Considering the ICD-O codes \[[@pone.0155669.ref011]\], we summarized the data in MS EXCEL (Microsoft, Redmond, WA) software with Persian letterings. The duplicated dada were removed as described in our previous study \[[@pone.0155669.ref010]\]. The data were computerized using SPSS (Chicago, IL) software, version 13.0. The results are presented as incidence rates of cases by site (ICD-O), sex, age, crude rate, and age-standardized rates per 100,000 person-years (ASRs), using the direct method of standardization to the world population \[[@pone.0155669.ref012]\]. In order to compare the ASR of 2007--2010 with 1998--2002, we used standardized rate ratio (SRR), as described previously ([S2 Table](#pone.0155669.s002){ref-type="supplementary-material"}) \[[@pone.0155669.ref012]\].

Ethical approval {#sec007}
----------------

This study was approved by the ethic committee of Shiraz University of medical Sciences with approval number of EC_P\_9398_9098. The ethic committee of Shiraz University of medical Sciences waived informed consent, as this was a retrospective analysis and patients were already consented for research purposes at the time of their recruitment for treatment. Our patients' records/information was concealed prior to analysis.

Results {#sec008}
=======

The principal cancer sites, ASRs as well as crude rates for both men and women in Fars province, Iran, 2007--2010 are shown in [Table 1](#pone.0155669.t001){ref-type="table"}. Based on calculated ASRs, the 5 most frequent cancers in women were breast (28.37 per 100,000), colon and rectum (7.49 per 100,000), stomach (5.56 per 100,000), thyroid (5.51 per 100,000), and bladder (3.93 per 100,000) ([Fig 2](#pone.0155669.g002){ref-type="fig"}); and the 5 most frequent types in men were bladder (15.60 per 100,000), prostate (12.99 per 100,000), stomach (11.21 per 100,000), colon and rectum (9.57 per 100,000), and leukemia (6.82 per 100,000) ([Fig 3](#pone.0155669.g003){ref-type="fig"}). The ASR for all cancers in men and women were 101.48 and 95.46 per 100,000 ([Table 1](#pone.0155669.t001){ref-type="table"}).

![Changing the incidence of top ten cancers in women based on age-standardized rates per 100,000 person-years (ASR) in Fars province, Iran during three time periods.\
This figure shows changes in the incidence of top ten cancers in women based on age-standardized rates per 100,000 person-years (ASR) in Fars province, Iran during 1985--1989, 1998--2002, and 2007--2010 time periods.](pone.0155669.g002){#pone.0155669.g002}

![Changing the incidence of top ten cancers in men based on age-standardized rates per 100,000 person-years (ASR) in Fars province, Iran during three time periods.\
This figure shows changes in the incidence of top ten cancers in men based on age-standardized rates per 100,000 person-years (ASR) in Fars province, Iran during 1985--1989, 1998--2002, and 2007--2010 time period.](pone.0155669.g003){#pone.0155669.g003}

10.1371/journal.pone.0155669.t001

###### Top ten cancers in women and men based on age-standardized rates per 100,000 person-years (ASR) in Fars province, Iran, 2007--2010.

![](pone.0155669.t001){#pone.0155669.t001g}

  Tumor site       ASR     95% CI         Crude rate   Tumor site       ASR      95% CI          Crude rate
  ---------------- ------- -------------- ------------ ---------------- -------- --------------- ------------
  Breast           28.37   26.89--29.86   23.35        Bladder          15.60    14.45--16.74    11.65
  Colon &rectum    7.49    6.69--8.29     5.64         Prostate         12.99    11.97--14.01    10.17
  Stomach          5.56    4.87--6.24     4.18         Stomach          11.21    10.24--12.18    8.52
  Thyroid          5.51    4.88--6.14     5.16         Colon &rectum    9.57     8.67--10.46     7.21
  Bladder          3.93    3.35--4.51     2.90         Leukemia         6.82     6.11--7.53      5.73
  Ovary            3.64    3.1--4.17      3.02         Lung             6.09     5.39--6.8       4.71
  Leukemia         3.49    2.97--4.01     2.98         Nervous system   4.44     3.87--5.01      3.90
  Nervous system   3.26    2.73--3.78     2.44         Larynx           3.93     3.34--4.52      2.78
  Lung             3.04    2.53--3.56     2.25         Kidney           3.81     3.24--4.38      2.84
  Cervix uteri     2.55    2.09--3.01     1.97         Esophagus        3.25     2.72--3.78      2.39
  Total            95.46   92.69--98.22   77.52        Total            101.48   98.61--104.35   79.76

Comparing the results of three time periods (1985--1989, 1998--2002, and 2007--2010) are shown in Tables [2](#pone.0155669.t002){ref-type="table"} and [3](#pone.0155669.t003){ref-type="table"} for women and men. The total trend of ASR of cancer for both sexes in Fars province is incremental. In women the total ASR was 41.70 per 100,000 in 1985--1989 that increased to 55.50 and 95.46 during 1998--2002 and 2007--2010 ([Table 2](#pone.0155669.t002){ref-type="table"}). Breast cancer was the most common cancer among women during all time periods. The incidence of breast cancer in women during 2007--2010 was about two and four times higher than 1998--2002 and 1985--1989. The incidence of colorectal cancer in women during 2007--2010 was about three and five times higher than 1998--2002 and 1985--1989.

10.1371/journal.pone.0155669.t002

###### Top ten cancers in women based on age-standardized rates per 100,000 person-years (ASR) and standardized rate ratio (SRR) in Fars province comparing to previous studies in Fars, GLOBOCAN 2008.

![](pone.0155669.t002){#pone.0155669.t002g}

  Tumor sites      Fars 1985--89   Fars 1998--02   Fars2007-10   SRR[\*](#t002fn001){ref-type="table-fn"} (95%)   GLOBOCAN^13^2008
  ---------------- --------------- --------------- ------------- ------------------------------------------------ ------------------
  Breast           7.40            13.00           28.37         2.2(1.9--2.5)                                    18.40
  Colon &rectum    1.50            2.60            7.49          2.9(2.4--3.5)                                    6.40
  Stomach          3.00            4.40            5.56          1.3(1.1--1.5)                                    9.00
  Thyroid          2.90            2.20            5.51          2.5(2.2--2.9)                                    2.30
  Bladder          2.00            1.90            3.93          2.1(1.8--2.4)                                    2.60
  Ovary            1.40            2.00            3.64          1.8(1.6--2.1)                                    3.10
  Leukemia         3.20            4.40            3.49          0.8(0.7--0.9)                                    4.00
  nervous system   1.10            2.20            3.26          1.5(1.3--1.8)                                    2.10
  Lung             1.50            2.90            3.04          1(0.9--1.2)                                      3.50
  Cervix uteri     2.30            1.50            2.55          1.7(1.5--2)                                      2.20
  Total            41.70           55.50           95.46         1.7(1.5--2)                                      87.50

\* SRR: **Standardized Rate Ratio, ASR2007-10/ASR 1998--02**

10.1371/journal.pone.0155669.t003

###### Top ten cancers in men based on age-standardized rates per 100,000 person-years (ASR) and standardized rate ratio (SRR) in Fars province comparing to previous studies in Fars, GLOBOCAN 2008.

![](pone.0155669.t003){#pone.0155669.t003g}

  Tumor sites      Fars 1985--89   Fars1998-02   Fars2007-10   SRR[\*](#t003fn001){ref-type="table-fn"} (95%)   GLOBOCAN^13^2008
  ---------------- --------------- ------------- ------------- ------------------------------------------------ ------------------
  Bladder          7.50            6.80          15.60         2.3(2--2.7)                                      11.20
  Prostate         3.00            3.50          12.99         3.7(3.1--4.4)                                    11.60
  Stomach          9.00            9.20          11.21         1.2(1--1.4)                                      21.90
  Colon &rectum    2.40            3.40          9.57          2.8(2.3--3.4)                                    8.70
  Leukemia         5.70            5.50          6.82          1.2(1.1--1.3)                                    7.70
  Lung             6.20            6.30          6.09          1(0.9--1.1)                                      9.10
  nervous system   1.90            3.00          4.44          1.5(1.3--1.7)                                    3.60
  Larynx           3.20            1.00          3.93          3.9(3.3--4.7)                                    3.50
  Kidney           0.97            1.30          3.81          2.9(2.4--3.5)                                    2.70
  Esophagus        3.50            2.00          3.25          1.6(1.4--1.9)                                    7.40
  Total            62.90           64.50         101.48        1.6(1.4--1.8)                                    126.10

\* SRR: **Standardized Rate Ratio, ASR2007-10/ASR 1998--02**

In men the total ASR was 62.9 per 100000 in 1985--1989 that increased to 64.50 and 101.48 during 1998--2002 and 2007--2010 ([Table 3](#pone.0155669.t003){ref-type="table"}). Although stomach cancer was the most common cancer among men during 1985--1989 and 1998--2002, in a recent study bladder cancer was the most common cancer among men in Fars province. The incidence of bladder cancer in men during 2007--2010 was about two times higher than 1998--2002 and 1985--1989. The incidence of colorectal cancer in men during 2007--2010 was about three times higher than 1998--2002 and 1985--1989.

Discussion {#sec009}
==========

This study shows the growing incidence rate of cancer in Fars province. Compared with 1998--2002, the incidence of breast, colorectal, and stomach cancers in women grew much more during 2007--2010. Compared with 1998--2002, the incidence of bladder, prostate and colorectal cancers in men grew much more during 2007--2010. The growing trend of cancer in Fars province follows the overall trend of cancer in the world and especially in developing countries \[[@pone.0155669.ref013]\]. The growing pattern of cancer compared with previous study in Fars could be multi factorial. Aging of population could be another issue. On average Fars population got 5 years older during a decade \[[@pone.0155669.ref007], [@pone.0155669.ref008]\]. Starting and intensification of new screening programs occurred during the same time period; Mammography for women and prostate exam for men during men\'s health day. Access to new diagnostic modalities such as new version of computerized tomography might also affect the higher diagnosis rate. Improved sanitation and decreased infectious diseases along with increasing population age, changing life styles including; more use of unsanitary fast foods, more food consumption, increasing transplantation operation and subsequently higher use of cytotoxic drug might all had contributed to this issue. Starting and establishing the population based cancer registries that occurred following parliament mandate to report all tissues "diagnosed or suspected of cancer" \[[@pone.0155669.ref005]\], and finally more applying information technology in the medical field including cancer could have played an important role.

Below we compare the incidence rates for top ten cancers in decreasing order from the present study with the rates from the previous provincial cancer registry. The implications of notable changes in incidence rates are also discussed.

Breast cancer {#sec010}
-------------

The incidence trend of breast cancer, as the most common cancer in women is growing and has risen by two fold each decade since 1980s \[[@pone.0155669.ref010]\]. Although this increase could be mainly due to the increased use of a screening program, but other factors such as decrease in protective factor like decrease in birth rate and breast-feeding rate should also be considered \[[@pone.0155669.ref014]\]. The breast cancer incidence was higher than other provinces \[[@pone.0155669.ref015]--[@pone.0155669.ref018]\] and Globocan 2008 (28.37 per 100,000 vs. 18.4 per 100,000) \[[@pone.0155669.ref013]\].

Bladder cancer {#sec011}
--------------

In the present study bladder cancer is the most common cancer in men (15.6 per 100,000) and fifth most common in women (3.93 per 100,000). Men to women ratio were 3.97:1 and were similar to Salehi's study \[[@pone.0155669.ref019]\] and other previous studies in Iran \[[@pone.0155669.ref020]\]. The incidence of bladder cancer has shown an incremental trend comparing to previous study \[[@pone.0155669.ref010]\]. The incremental trend of bladder cancer cannot solely be explained by improvement in diagnostic methods, as bladder cancer can be diagnosed by cystoscopy and biopsy for many years \[[@pone.0155669.ref021]\]. Possible explanation for the increase in ASR for bladder cancer may be due to increase in number of smokers and exposure to other industrial carcinogens and population \[[@pone.0155669.ref022]\]. There are reports of long term oncogenic effects of opium usage which may have contributed to this increasing trend \[[@pone.0155669.ref023]\].

Prostate cancer {#sec012}
---------------

Prostate cancer with 12.99 per 100,000 incidences is the second most common cancer in men in Fars province. It had risen four times when compared to a previous study in Fars \[[@pone.0155669.ref010]\]. This increase in incidence of prostate cancer cannot not only due to population based screening program for prostate cancer but also due to aging population and increase in rate of smokers \[[@pone.0155669.ref024], [@pone.0155669.ref025]\].

Stomach cancer {#sec013}
--------------

In this study stomach cancer is the third most common cancer in both genders. Although the incidence of stomach cancer has relatively increased from 4.4 to 5.56 per 100,000 in women and 9.2 to 11.21 per 100,000 in men comparing with older Fars study \[[@pone.0155669.ref010]\], but these incidences are much lower than those reported in GLOBOCAN 2008 \[[@pone.0155669.ref013]\], and the northern provinces of Iran \[[@pone.0155669.ref015]--[@pone.0155669.ref018]\]. The lower rate of stomach cancer in our province could be due to lower H. pylori infection \[[@pone.0155669.ref026]\], and less consumption of smoked or preserved foods in Fars population.

The proximal gastric cancer compared to distal gastric cancer has a negative correlation with H.pylori infection \[[@pone.0155669.ref027]\]. Since no distinction has been made between these two subtypes, thus one cannot be sure of absolute increase in the number of gastric cancers of its subtypes. It is postulated that this might be due to more proximal gastric cancers. Some of these cancers were previously mistaken for distal esophageal adenocarcinoma and better classification might have had an effect on this increase of ASR for gastric cancer.

Colorectal cancer {#sec014}
-----------------

Colorectal cancer is the second most common cancer in women and fourth in men. Comparing with previous study \[[@pone.0155669.ref010]\] the incidence of colorectal cancer had risen by three fold. Changing dietary habit, consumption of fast food and low fiber diet \[[@pone.0155669.ref014]\], can be associated with increased colonoscopy facility could explain the greater incidence of colorectal cancer in our region.

Leukemia {#sec015}
--------

The incidence of leukemia in men was nearly twice as much as women (6.82 vs. 3.49 per 100,000). The main reason was that men were more exposed to risk factors such as; smoking and occupational and environmental hazards like chemical agents, pesticides and radiation \[[@pone.0155669.ref028], [@pone.0155669.ref029]\].

Lung and larynx cancer {#sec016}
----------------------

The incidence of lung cancer in both genders did not show any significant changes compared with 1998--2002 study \[[@pone.0155669.ref010]\]. One explanation is that in previous study some misclassification of metastatic lung cancer as primary lung cancer had occurred, however, recently with progress in radiologic technology and diagnostic laboratory (Immunohistochemistry) this misclassification has been rectified. On the other hands, based on previous study more than 80% of lung cancer had been verified microscopically which means in our cancer registry system, patients with lung cancer could have been labeled as pneumonia or other impressions \[[@pone.0155669.ref010]\].

Thyroid cancer {#sec017}
--------------

Thyroid cancer is the fourth most common amongst women (5.51 per 100,000), while in men this incidence was 1.64 per 100,000. A woman to men ratio in 1998--2002 was 2, but this ratio had risen to 3.35 in a recent study. Both the increasing use of diagnostic technologies and a true increase in thyroid cancer incidence could have played a role in this issue. The women in Fars body mass index (BMI) had increased more than men \[[@pone.0155669.ref030]\], and obesity has a strongest link to thyroid cancer risk among other risk factors \[[@pone.0155669.ref031]\].

Nervous system cancer {#sec018}
---------------------

Nervous system cancer showed an increased incidence rate among both genders during 2007--2010 compared with 1998--2002. Men predominance pattern of nervous system cancer was similar in the present study compared with older study in Fars province \[[@pone.0155669.ref032]\]. Whilst high dose ionizing radiation is an established risk factor for this group of tumors \[[@pone.0155669.ref033]\], imaging modalities for diagnosis of nervous system cancer was more available during 2007--2010 compared to 1998--2002.

Esophageal cancer {#sec019}
-----------------

In Fars province, esophageal cancer was much lower than north of Iran, nevertheless the incidence of esophageal cancer had increased during 2007--2010 period (Women 2.04 vs. 1.4 and men 3.25 vs. 2 per 100,000). There are two major types of esophageal cancer: squamous cell carcinoma (SCC) and adenocarcinoma (AC). Most of esophageal cancers in northern Iran were SCC \[[@pone.0155669.ref034]\]. The risk factors for these two subtypes are very different. Exposure to nitrosamines, polyaromatic hydrocarbons, smoked food, hot beverages and opium are considered as risk factors for SCC, while AC is mostly related to chronic gastroesophageal reflux disease \[[@pone.0155669.ref035]\]. However, the data that distinct these two subtypes is not available. But there has been a huge increase in incidence of gastroesophageal reflux disease in recent years in Iran \[[@pone.0155669.ref036]\]. This may have contributed to some increase in ASR of esophageal cancer.

Ovarian and cervical cancer {#sec020}
---------------------------

Both ovarian (3.64 vs. 2 per 100,000) and cervical (2.55 vs. 1.5 per 100,000) cancer increased during 2007--2010. Part of this increase was probably related to better diagnosis due to more screening and diagnostic modes. Screening for cervical cancer was part of the basic health service in public health facilities. A diagnostic mode for ovarian cancer is mainly sonography which is now more widely available in the province. Older age of the studied population might have also contributed to this issue.

Limitations {#sec021}
-----------

Considering that the methodology of our study was retrospective, this study has several potential limitations. Our cancer registry only recorded cancer cases instead of patients, so in situation that a patient had more than one primary cancer, the same person was counted more than once \[[@pone.0155669.ref037]\]. Although we did our best to omit duplicated reports, but possible duplication may have occurred equally across all types of cancers and in both genders, consequently the possibility of occurrence of systematic errors in our analysis would be highly unlikely. Since our cancer registry system emphasis on documentation of cancer cases using pathologic and microscopic verification, our findings could have underestimate the incidence of cancer in our region.

Conclusions {#sec022}
===========

This study shows growing incidence rate of cancer in Fars province, southern Iran. The colorectal cancer in both genders has increased and its pattern was similar to western countries. In men, bladder and prostate cancers had an increasing rate and their incidence in the present study was greater than stomach cancer. However, breast cancer is the most common type of cancer in women as it was shown in previous study.

Supporting Information {#sec023}
======================

###### Dataset of the cancer cases in Fars province, Iran, 2007--2010.

(XLS)
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Click here for additional data file.

###### Calculation of standardized rate ratio (SRR) between ASR 2007--10 and ASR 1998--02.

(XLSX)

###### 

Click here for additional data file.

We would like to thank all cancer registry data providers in Fars province, especially the staff of the Cancer Surveillance Department of the Deputy of Health at Shiraz University of Medical Sciences. The authors wish to thank the deputy chancellor of Shiraz University of Medical Sciences for approving the proposal of project (number 93-01-62-9098, Shiraz University of Medical Sciences). The authors would like to thank the Research Consultation Center (RCC) for their invaluable assistance in editing this article.

[^1]: **Competing Interests:**The authors have declared that no competing interests exist.

[^2]: Conceived and designed the experiments: SMM KBL MM. Performed the experiments: SMM KBL BH SHT MM ZK. Analyzed the data: SMM BH SHT. Contributed reagents/materials/analysis tools: SMM KBL BH SHT MM ZK. Wrote the paper: SMM KBL BH SHT MM ZK. Contribution in critical revision and final approval of the manuscript: SMM KBL BH SHT MM ZK.

[^3]: Current address: Kamran B Lankarani, Health Policy Research Center, Shiraz University of Medical Sciences, 7134845794, Shiraz, Iran
